Business First Bancshares, Inc. current report, 20 October 2021

Business Context and Reporting Period

Business First Bancshares, Inc. (BFST), the parent holding company of b1BANK, filed this Form 8-K on October 20, 2021. The filing primarily announces the entry into a definitive merger agreement with Texas Citizens Bancorp, Inc. (TCBI). Additionally, the filing references the announcement of consolidated financial results for the third quarter ended September 30, 2021, and the declaration of a quarterly dividend.

Key Financial Metrics and Transaction Valuation

  • Transaction Value: Approximately $52.9 million in aggregate, based on BFST's closing stock price of $25.30 on October 19, 2021.
  • Exchange Ratio: Each share of TCBI common stock will be converted into 0.7038 shares of BFST common stock, plus cash for fractional shares.
  • Dividend Declaration: A cash dividend of $0.12 per share was declared for shareholders of record on November 15, 2021, payable on November 30, 2021.
  • Termination Fee: TCBI is obligated to pay a termination fee of $2,000,000 under specific circumstances related to the pursuit of an alternative transaction.
  • Financial Results: The filing references Q3 2021 results but does not provide specific revenue, profit, or cash flow figures within the text of this 8-K; these are contained in attached exhibits.

Material Changes and Transaction Structure

The most significant material change is the proposed merger where TCBI will merge into BFST, with BFST as the surviving corporation. Immediately following, Texas Citizens Bank, National Association will merge into b1BANK. Key structural details include:

  • Option Treatment: Outstanding TCBI options will cease to be outstanding and replaced with fully-vested substitute BFST options mirroring the original economic terms.
  • Non-Solicitation: TCBI is restricted from soliciting alternative proposals, though a "fiduciary out" allows the board to consider superior unsolicited offers, granting BFST a right to match.
  • Non-Competition: TCBI directors and executives have entered into non-competition agreements for two years post-merger.

Guidance, Outlook, and Risks

Outlook and Timeline: The merger is expected to close in the first quarter of 2022, subject to regulatory approvals and TCBI shareholder approval. Management anticipates cost savings and integration benefits, though specific quantitative guidance is not detailed in this filing.

Risks and Contingencies:

  • Closing Conditions: Completion is contingent on regulatory approvals and shareholder votes.
  • Integration Risks: Potential difficulties in integrating businesses, realizing cost savings, or business disruption.
  • Market Risks: Changes in interest rates, capital markets, and inflation could impact the combined entity.
  • Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations regarding the earn-back period for dilution and integration success.

Investor Verification Checklist

  • Verify the final exchange ratio and any adjustments to the $52.9 million transaction value upon closing.
  • Confirm the receipt of all necessary regulatory approvals and the outcome of the TCBI shareholder vote.
  • Review the attached Q3 2021 press release (Exhibit 99.1) and investor presentation (Exhibit 99.3) for specific revenue, net income, and asset quality metrics not included in this summary.
  • Monitor the filing of the Form S-4 Registration Statement for detailed proxy information and risk factors.
  • Assess the potential dilution impact of the 0.7038 share exchange ratio on existing BFST shareholders.